FDA NDC Directory · JSON-LD · Markdown

LORAZEPAM

NDC 61919-062 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerDIRECT RX
Marketing categoryAbbreviated NDA (generic) · App ANDA078203
Dosage form / routeTABLET · ORAL
Active ingredientsLORAZEPAM (.5 mg/1)
Marketing started20170210
Package count2

External sources

Source: openFDA. Public-domain (CC0).